Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunometabolic Interplay in the Tumor Microenvironment
Irem Kaymak, Kelsey S. Williams, Jason R. Cantor, et al.
Cancer Cell (2020) Vol. 39, Iss. 1, pp. 28-37
Open Access | Times Cited: 261

Showing 1-25 of 261 citing articles:

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 750
Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment
Han Luo, Xuyang Xia, Li‐Bin Huang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 292
Resistance Mechanisms to Anti-PD Cancer Immunotherapy
Matthew D. Vesely, Tianxiang Zhang, Lieping Chen
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 45-74
Closed Access | Times Cited: 261
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
Sahar Mafi, Behzad Mansoori, Shahram Taeb, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 133
CRISPR screens in physiologic medium reveal conditionally essential genes in human cells
Nicholas J. Rossiter, Kimberly S. Huggler, Charles H. Adelmann, et al.
Cell Metabolism (2021) Vol. 33, Iss. 6, pp. 1248-1263.e9
Open Access | Times Cited: 114
Carbon source availability drives nutrient utilization in CD8+ T cells
Irem Kaymak, Katarzyna M. Luda, Lauren R. Duimstra, et al.
Cell Metabolism (2022) Vol. 34, Iss. 9, pp. 1298-1311.e6
Open Access | Times Cited: 109
Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
Miljana Nenkov, Yunxia Ma, Nikolaus Gaßler, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6262-6262
Open Access | Times Cited: 106
Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth
Hongyun Zhao, Da Teng, Lifeng Yang, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1660-1673
Open Access | Times Cited: 103
Control of immunity via nutritional interventions
Nicholas Collins, Yasmine Belkaid
Immunity (2022) Vol. 55, Iss. 2, pp. 210-223
Open Access | Times Cited: 79
Spatial multi-omics analyses of the tumor immune microenvironment
Wan-Chen Hsieh, Bugi Ratno Budiarto, Yi‐Fu Wang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 76
Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer
Qing Xin, Wenjing Xu, Shengli Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack
Yuan Fang, Weiren Liu, Zheng Tang, et al.
Hepatology (2022) Vol. 77, Iss. 1, pp. 109-123
Closed Access | Times Cited: 72
The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives
Shuo Wang, Si-Tong Sun, Xinyue Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2943-2943
Open Access | Times Cited: 70
Single-cell sequencing of ascites fluid illustrates heterogeneity and therapy-induced evolution during gastric cancer peritoneal metastasis
Xuanzhang Huang, Min-Jiao Pang, Jiayi Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 47
PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
Yi-Min Zheng, Yining Wang, Lu Zhou, et al.
Advanced Science (2023) Vol. 10, Iss. 29
Open Access | Times Cited: 43
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment
Yuze Hua, Sen Yang, Yalu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 19
Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1
W. Ren, Zilong Xu, Yating Chang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
Andrea Nicolini, Paola Ferrari
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
Critical roles and clinical perspectives of RNA methylation in cancer
Ganglei Li, Qinfan Yao, Peixi Liu, et al.
MedComm (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 17
13 C metabolite tracing reveals glutamine and acetate as critical in vivo fuels for CD8 T cells
H. Eric, Michael S. Dahabieh, Lisa M. DeCamp, et al.
Science Advances (2024) Vol. 10, Iss. 22
Open Access | Times Cited: 16
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 4
A Self-Driven Bioreactor Based on Bacterium–Metal–Organic Framework Biohybrids for Boosting Chemotherapy via Cyclic Lactate Catabolism
Jiawei Wang, Qi‐Wen Chen, Guo‐Feng Luo, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17870-17884
Closed Access | Times Cited: 90
The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy
Juan Li, Guo Zhang, Chenguang Liu, et al.
Theranostics (2021) Vol. 12, Iss. 1, pp. 87-104
Open Access | Times Cited: 78
The therapeutic implications of immunosuppressive tumor aerobic glycolysis
Bradley I. Reinfeld, W. Kimryn Rathmell, Tae Kon Kim, et al.
Cellular and Molecular Immunology (2021) Vol. 19, Iss. 1, pp. 46-58
Open Access | Times Cited: 75
Page 1 - Next Page

Scroll to top